{"entity":{"type":"insider","cik":"0001814899","url":"/insider/0001814899","json_url":"/insider/0001814899.json","name":"Lloyd George W.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":81,"n_filings":25,"first":"2020-06-22","last":"2025-12-19","span_basis":"filed_date"},"name_variants":[{"name":"Lloyd George W.","source":"filing","n_filings":25,"first_seen":"2020-06-22","last_seen":"2025-12-19"}],"transactions":[{"id":5133788,"accession":"0001814899-25-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001814899-25-000010","line_url":"/filing/0001814899-25-000010#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30654.0,"shares_display":"30,654","price_per_share":38.4959,"price_display":"38.50","price_state":"stated","total_value":1180053.3186,"total_display":"1,180,053.32","total_whole":"1,180,053","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"},{"id":5133783,"accession":"0001814899-25-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001814899-25-000010","line_url":"/filing/0001814899-25-000010#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79346.0,"shares_display":"79,346","price_per_share":38.5688,"price_display":"38.57","price_state":"stated","total_value":3060280.0048,"total_display":"3,060,280.00","total_whole":"3,060,280","shares_owned_after":30654.0,"shares_owned_after_display":"30,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":5099794,"accession":"0001814899-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001814899-25-000008","line_url":"/filing/0001814899-25-000008#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110000.0,"shares_display":"110,000","price_per_share":39.7728,"price_display":"39.77","price_state":"stated","total_value":4375008.0,"total_display":"4,375,008.00","total_whole":"4,375,008","shares_owned_after":110000.0,"shares_owned_after_display":"110,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider"},{"id":5099788,"accession":"0001814899-25-000006","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001814899-25-000006","line_url":"/filing/0001814899-25-000006","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135426.0,"shares_display":"135,426","price_per_share":38.34312594775006,"price_display":"38.34","price_state":"stated","total_value":5192656.1746,"total_display":"5,192,656.17","total_whole":"5,192,656","shares_owned_after":10712.0,"shares_owned_after_display":"10,712","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-21","scope":"insider","n_lines":8},{"id":8254110,"accession":"0001209191-23-034792","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-034792","line_url":"/filing/0001209191-23-034792#line-4","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79099.0,"shares_display":"79,099","price_per_share":33.8158,"price_display":"33.82","price_state":"stated","total_value":2674795.9642,"total_display":"2,674,795.96","total_whole":"2,674,796","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-06","scope":"insider"},{"id":8254107,"accession":"0001209191-23-034792","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-034792","line_url":"/filing/0001209191-23-034792#line-3","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19215.0,"shares_display":"19,215","price_per_share":33.5387,"price_display":"33.54","price_state":"stated","total_value":644446.1205,"total_display":"644,446.12","total_whole":"644,446","shares_owned_after":109099.0,"shares_owned_after_display":"109,099","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-06","scope":"insider"},{"id":8254104,"accession":"0001209191-23-034792","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-034792","line_url":"/filing/0001209191-23-034792","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93907.0,"shares_display":"93,907","price_per_share":33.64334122589371,"price_display":"33.64","price_state":"stated","total_value":3159345.2445,"total_display":"3,159,345.24","total_whole":"3,159,345","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-06","scope":"insider","n_lines":2},{"id":8019587,"accession":"0001209191-23-021648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-021648","line_url":"/filing/0001209191-23-021648#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12779.0,"shares_display":"12,779","price_per_share":37.0268,"price_display":"37.03","price_state":"stated","total_value":473165.4772,"total_display":"473,165.48","total_whole":"473,165","shares_owned_after":212221.0,"shares_owned_after_display":"212,221","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-30","scope":"insider"},{"id":8019585,"accession":"0001209191-23-021648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021648","line_url":"/filing/0001209191-23-021648#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":37.0613,"price_display":"37.06","price_state":"stated","total_value":3706130.0,"total_display":"3,706,130.00","total_whole":"3,706,130","shares_owned_after":225000.0,"shares_owned_after_display":"225,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-30","scope":"insider"},{"id":7949578,"accession":"0001209191-23-013398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-013398","line_url":"/filing/0001209191-23-013398#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":37.2663,"price_display":"37.27","price_state":"stated","total_value":931657.5,"total_display":"931,657.50","total_whole":"931,658","shares_owned_after":325000.0,"shares_owned_after_display":"325,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-27","scope":"insider"},{"id":6957743,"accession":"0001209191-22-058450","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-058450","line_url":"/filing/0001209191-22-058450","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16369.0,"shares_display":"16,369","price_per_share":43.182083853625755,"price_display":"43.18","price_state":"stated","total_value":706847.5306,"total_display":"706,847.53","total_whole":"706,848","shares_owned_after":130000.0,"shares_owned_after_display":"130,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-22","scope":"insider","n_lines":2},{"id":6957737,"accession":"0001209191-22-058450","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058450","line_url":"/filing/0001209191-22-058450","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23631.0,"shares_display":"23,631","price_per_share":43.10943440819263,"price_display":"43.11","price_state":"stated","total_value":1018719.0445,"total_display":"1,018,719.04","total_whole":"1,018,719","shares_owned_after":144469.0,"shares_owned_after_display":"144,469","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider","n_lines":2},{"id":6788036,"accession":"0001209191-22-056677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-056677","line_url":"/filing/0001209191-22-056677","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & CLO)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & CLO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & CLO","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":43.85225,"price_display":"43.85","price_state":"stated","total_value":2192612.5,"total_display":"2,192,612.50","total_whole":"2,192,613","shares_owned_after":165000.0,"shares_owned_after_display":"165,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-14","scope":"insider","n_lines":2},{"id":6657587,"accession":"0001209191-22-045451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-045451","line_url":"/filing/0001209191-22-045451#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8995.0,"shares_display":"8,995","price_per_share":43.9253,"price_display":"43.93","price_state":"stated","total_value":395108.0735,"total_display":"395,108.07","total_whole":"395,108","shares_owned_after":201114.0,"shares_owned_after_display":"201,114","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-11","scope":"insider"},{"id":6657584,"accession":"0001209191-22-045451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045451","line_url":"/filing/0001209191-22-045451#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11859.0,"shares_display":"11,859","price_per_share":43.9161,"price_display":"43.92","price_state":"stated","total_value":520801.0299,"total_display":"520,801.03","total_whole":"520,801","shares_owned_after":210109.0,"shares_owned_after_display":"210,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-11","scope":"insider"},{"id":6786352,"accession":"0001209191-22-043689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043689","line_url":"/filing/0001209191-22-043689#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4046.0,"shares_display":"4,046","price_per_share":43.9676,"price_display":"43.97","price_state":"stated","total_value":177892.9096,"total_display":"177,892.91","total_whole":"177,893","shares_owned_after":221968.0,"shares_owned_after_display":"221,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-08-01","scope":"insider"},{"id":6657370,"accession":"0001209191-22-043286","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-043286","line_url":"/filing/0001209191-22-043286","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25100.0,"shares_display":"25,100","price_per_share":43.76274900398406,"price_display":"43.76","price_state":"stated","total_value":1098445.0,"total_display":"1,098,445.00","total_whole":"1,098,445","shares_owned_after":380000.0,"shares_owned_after_display":"380,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":6657365,"accession":"0001209191-22-043286","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-043286","line_url":"/filing/0001209191-22-043286","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19329.0,"shares_display":"19,329","price_per_share":43.098280381809715,"price_display":"43.10","price_state":"stated","total_value":833046.6615,"total_display":"833,046.66","total_whole":"833,047","shares_owned_after":226114.0,"shares_owned_after_display":"226,114","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":6657359,"accession":"0001209191-22-043286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-043286","line_url":"/filing/0001209191-22-043286","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30671.0,"shares_display":"30,671","price_per_share":42.930052414332756,"price_display":"42.93","price_state":"stated","total_value":1316707.6376,"total_display":"1,316,707.64","total_whole":"1,316,708","shares_owned_after":410443.0,"shares_owned_after_display":"410,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":6148375,"accession":"0001209191-22-032900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-032900","line_url":"/filing/0001209191-22-032900#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13974.0,"shares_display":"13,974","price_per_share":40.7724,"price_display":"40.77","price_state":"stated","total_value":569753.5176,"total_display":"569,753.52","total_whole":"569,754","shares_owned_after":430000.0,"shares_owned_after_display":"430,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6148372,"accession":"0001209191-22-032900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-032900","line_url":"/filing/0001209191-22-032900#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86026.0,"shares_display":"86,026","price_per_share":40.2127,"price_display":"40.21","price_state":"stated","total_value":3459337.7302,"total_display":"3,459,337.73","total_whole":"3,459,338","shares_owned_after":443974.0,"shares_owned_after_display":"443,974","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":6752399,"accession":"0001209191-22-031924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-031924","line_url":"/filing/0001209191-22-031924#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":40.2677,"price_display":"40.27","price_state":"stated","total_value":4026770.0,"total_display":"4,026,770.00","total_whole":"4,026,770","shares_owned_after":530000.0,"shares_owned_after_display":"530,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":5531850,"accession":"0001209191-21-065639","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-065639","line_url":"/filing/0001209191-21-065639#line-4","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84148.0,"shares_display":"84,148","price_per_share":42.3876,"price_display":"42.39","price_state":"stated","total_value":3566831.7648,"total_display":"3,566,831.76","total_whole":"3,566,832","shares_owned_after":630000.0,"shares_owned_after_display":"630,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-18","scope":"insider"},{"id":5531846,"accession":"0001209191-21-065639","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-065639","line_url":"/filing/0001209191-21-065639","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165852.0,"shares_display":"165,852","price_per_share":42.386353566432724,"price_display":"42.39","price_state":"stated","total_value":7029861.5117,"total_display":"7,029,861.51","total_whole":"7,029,862","shares_owned_after":523201.0,"shares_owned_after_display":"523,201","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider","n_lines":3},{"id":5293546,"accession":"0001209191-21-048317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-048317","line_url":"/filing/0001209191-21-048317","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13362.0,"shares_display":"13,362","price_per_share":39.7794106870229,"price_display":"39.78","price_state":"stated","total_value":531532.4856,"total_display":"531,532.49","total_whole":"531,532","shares_owned_after":780000.0,"shares_owned_after_display":"780,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider","n_lines":2},{"id":4760560,"accession":"0000899243-21-028335","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-028335","line_url":"/filing/0000899243-21-028335","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23049.0,"shares_display":"23,049","price_per_share":42.00841626534774,"price_display":"42.01","price_state":"stated","total_value":968251.9865,"total_display":"968,251.99","total_whole":"968,252","shares_owned_after":788449.0,"shares_owned_after_display":"788,449","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-14","scope":"insider","n_lines":2},{"id":4760552,"accession":"0000899243-21-028335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-028335","line_url":"/filing/0000899243-21-028335#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":42.04,"price_display":"42.04","price_state":"stated","total_value":4204.0,"total_display":"4,204.00","total_whole":"4,204","shares_owned_after":806430.0,"shares_owned_after_display":"806,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":4308939,"accession":"0000950103-21-010244","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950103-21-010244","line_url":"/filing/0000950103-21-010244","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49059.0,"shares_display":"49,059","price_per_share":42.04710134328054,"price_display":"42.05","price_state":"stated","total_value":2062788.7448,"total_display":"2,062,788.74","total_whole":"2,062,789","shares_owned_after":806530.0,"shares_owned_after_display":"806,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-08","scope":"insider","n_lines":2},{"id":4308930,"accession":"0000950103-21-010244","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950103-21-010244","line_url":"/filing/0000950103-21-010244","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":42.009655172413794,"price_display":"42.01","price_state":"stated","total_value":121828.0,"total_display":"121,828.00","total_whole":"121,828","shares_owned_after":847197.0,"shares_owned_after_display":"847,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider","n_lines":2},{"id":4308922,"accession":"0000950103-21-010244","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950103-21-010244","line_url":"/filing/0000950103-21-010244#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814899","owner_name":"Lloyd George W.","owner_display_name":"Lloyd George W.","owner_url":"/insider/0001814899","role":"Officer (EVP, Investments & GC)","role_mark":"O","role_mark_label":"Officer (EVP, Investments & GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Investments & GC","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30303.0,"shares_display":"30,303","price_per_share":42.4059,"price_display":"42.41","price_state":"stated","total_value":1285025.9877,"total_display":"1,285,025.99","total_whole":"1,285,026","shares_owned_after":849697.0,"shares_owned_after_display":"849,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider"}],"collapsed":true,"next_cursor":"2021-07-06|4308922","ledger_fault":false,"count":{"value":81,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":79,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":81},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802768","name":"Royalty Pharma plc","url":"/issuer/0001802768","role":"Officer (EVP, Investments & CLO)","n_filings":25,"first_seen":"2020-06-22","last_seen":"2025-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001814899","retrieved_at":"2026-08-24T17:36:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}